Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedUpdated page to v3.2.0 with a new government operating status notice; removed v3.1.0.SummaryDifference4%
- Check23 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.5%
- Check37 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; no substantive content changes are shown beyond the revision tag. The removal of the 'Back to Top' element is a minor UI change.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check51 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a facility name and location details, as well as new MedlinePlus related topics on drug safety and diabetes prevention. Notably, the revision number has been updated to v3.0.0.SummaryDifference5%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.